EG24124A - Pharmaceutical compositions for the treatment of type-II diabetes mellitus - Google Patents

Pharmaceutical compositions for the treatment of type-II diabetes mellitus

Info

Publication number
EG24124A
EG24124A EG2002111281A EG2002111281A EG24124A EG 24124 A EG24124 A EG 24124A EG 2002111281 A EG2002111281 A EG 2002111281A EG 2002111281 A EG2002111281 A EG 2002111281A EG 24124 A EG24124 A EG 24124A
Authority
EG
Egypt
Prior art keywords
treatment
type
pharmaceutical compositions
diabetes mellitus
mellitus
Prior art date
Application number
EG2002111281A
Other languages
English (en)
Inventor
Alessandro Tosetti
Original Assignee
Menarini Int Operations Lu Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11442301&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EG24124(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Menarini Int Operations Lu Sa filed Critical Menarini Int Operations Lu Sa
Application granted granted Critical
Publication of EG24124A publication Critical patent/EG24124A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EG2002111281A 2001-11-29 2002-11-27 Pharmaceutical compositions for the treatment of type-II diabetes mellitus EG24124A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2001FI000230A ITFI20010230A1 (it) 2001-11-29 2001-11-29 Composizioni farmaceutiche per il trattamento del diabete mellito di tipo ii

Publications (1)

Publication Number Publication Date
EG24124A true EG24124A (en) 2008-07-07

Family

ID=11442301

Family Applications (1)

Application Number Title Priority Date Filing Date
EG2002111281A EG24124A (en) 2001-11-29 2002-11-27 Pharmaceutical compositions for the treatment of type-II diabetes mellitus

Country Status (39)

Country Link
US (1) US20050053661A1 (pl)
EP (1) EP1458364B1 (pl)
JP (1) JP4474162B2 (pl)
KR (1) KR20040079898A (pl)
CN (1) CN1596103B (pl)
AR (1) AR037407A1 (pl)
AT (1) ATE387190T1 (pl)
AU (1) AU2002358061B2 (pl)
BR (1) BR0214403A (pl)
CA (1) CA2466677A1 (pl)
CO (1) CO5590906A2 (pl)
CY (1) CY1107966T1 (pl)
DE (1) DE60225331T2 (pl)
DK (1) DK1458364T3 (pl)
EA (1) EA006766B1 (pl)
EG (1) EG24124A (pl)
ES (1) ES2302862T3 (pl)
HN (1) HN2002000341A (pl)
HR (1) HRP20040501A2 (pl)
HU (1) HUP0402154A3 (pl)
IL (1) IL162143A0 (pl)
IT (1) ITFI20010230A1 (pl)
MA (1) MA27087A1 (pl)
MX (1) MXPA04004974A (pl)
MY (1) MY141243A (pl)
NO (1) NO20042713L (pl)
NZ (1) NZ533779A (pl)
PA (1) PA8559801A1 (pl)
PE (1) PE20030580A1 (pl)
PL (1) PL206016B1 (pl)
PT (1) PT1458364E (pl)
RS (1) RS50937B (pl)
SI (1) SI1458364T1 (pl)
SV (1) SV2004001415A (pl)
TN (1) TNSN04095A1 (pl)
UA (1) UA81615C2 (pl)
UY (1) UY27549A1 (pl)
WO (1) WO2003045355A1 (pl)
ZA (1) ZA200404880B (pl)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002055009A1 (en) * 2001-01-12 2002-07-18 Sun Pharmaceutical Industries Limited Spaced drug delivery system
WO2003105809A1 (en) 2002-06-17 2003-12-24 Themis Laboratories Private Limited Multilayer tablets containing thiazolidinedione and biguanides and methods for producing them
US7785627B2 (en) 2002-09-20 2010-08-31 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US9060941B2 (en) 2002-09-20 2015-06-23 Actavis, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
RU2350327C2 (ru) 2003-04-29 2009-03-27 Ориксиджен Серапьютикс, Инкорпорэйтд Составы, вызывающие потерю веса
PE20061245A1 (es) * 2005-03-30 2007-01-06 Generex Pharm Inc Composiciones para la transmision transmucosa oral de la metformina
TWI471145B (zh) * 2005-06-13 2015-02-01 Bristol Myers Squibb & Gilead Sciences Llc 單一式藥學劑量型
TW201811315A (zh) * 2006-11-09 2018-04-01 美商歐瑞根治療有限公司 層狀醫藥調配物
ITMI20062254A1 (it) * 2006-11-24 2008-05-25 Acraf Uso di un acido metossi-alcanoico dell'indazolo per preparare una composizione farmaceutca
EP2303025A4 (en) 2008-05-30 2012-07-04 Orexigen Therapeutics Inc METHOD FOR TREATING DIGITAL FAT SWITCHES
CA2638240C (en) 2008-08-29 2010-02-02 Alexander Macgregor Method of treating dysglycemia and glucose excursions
RU2398572C1 (ru) * 2009-05-18 2010-09-10 Государственное образовательное учреждение высшего профессионального образования "Санкт-Петербургская государственная медицинская академия им. И.И. Мечникова Федерального агентства по здравоохранению и социальному развитию" Способ лечения больных сахарным диабетом 2 типа
EP3659604A1 (en) 2010-01-11 2020-06-03 Nalpropion Pharmaceuticals, Inc. Methods of providing weight loss therapy in patients with major depression
RU2483717C2 (ru) * 2010-11-22 2013-06-10 Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") Фармацевтическая композиция для лечения диабета (варианты)
US9480663B2 (en) 2011-01-07 2016-11-01 Elcelyx Therapeutics, Inc. Biguanide compositions and methods of treating metabolic disorders
US9211263B2 (en) 2012-01-06 2015-12-15 Elcelyx Therapeutics, Inc. Compositions and methods of treating metabolic disorders
US9572784B2 (en) 2011-01-07 2017-02-21 Elcelyx Therapeutics, Inc. Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk
LT2661266T (lt) 2011-01-07 2020-12-10 Anji Pharma (Us) Llc Gydimo būdai chemosensorinio receptoriaus ligando pagrindu
US11974971B2 (en) 2011-01-07 2024-05-07 Anji Pharmaceuticals Inc. Compositions and methods for treating metabolic disorders
US8796338B2 (en) 2011-01-07 2014-08-05 Elcelyx Therapeutics, Inc Biguanide compositions and methods of treating metabolic disorders
US11759441B2 (en) 2011-01-07 2023-09-19 Anji Pharmaceuticals Inc. Biguanide compositions and methods of treating metabolic disorders
CN104254325A (zh) 2012-01-06 2014-12-31 埃尔舍利克斯治疗公司 双胍组合物和治疗代谢性病症的方法
CN110693867A (zh) 2012-01-06 2020-01-17 埃尔舍利克斯治疗公司 用于治疗代谢性病症的组合物和方法
PT3730132T (pt) 2012-06-06 2022-08-16 Nalpropion Pharmaceuticals Llc Composição para utilização num método de tratamento de excesso de peso e obesidade em doentes com alto risco cardiovascular
CN107072997A (zh) 2014-11-11 2017-08-18 盐野义制药株式会社 含有对光不稳定的药物的多层片剂
KR101750690B1 (ko) * 2015-10-28 2017-06-27 주식회사 종근당 메트포르민 및 로베글리타존을 포함하는 약제학적 조성물
CN105596339A (zh) * 2015-12-23 2016-05-25 青岛海之源智能技术有限公司 一种二甲双胍阿昔莫司复方组合物及制备方法
DK3804716T3 (da) 2018-05-31 2025-03-03 Hua Medicine Shanghai Ltd Farmaceutisk kombination, sammensætning og kombinationspræparat omfattende glucokinase-aktivator og sglt-2-inhibitor og fremgangsmåder til fremstilling og anvendelser deraf
CN110128305A (zh) * 2019-05-10 2019-08-16 天津大学 二甲双胍-甲苯磺丁脲新盐型、其制备方法及医药用途
JP2021120357A (ja) * 2020-01-30 2021-08-19 サンノーバ株式会社 錠剤
GB2599950A (en) * 2020-10-16 2022-04-20 Zentiva Ks Pharmaceutical compositions with low amounts of nitrosamine impurities and methods for producing the same
CN113143940A (zh) * 2020-12-30 2021-07-23 成都恒瑞制药有限公司 一种抗糖尿病药物组合物的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2347531A1 (de) * 1973-09-21 1975-04-30 Hoechst Ag Arzneizubereitungen zur oralen diabetes-behandlung
IT1276130B1 (it) * 1995-11-14 1997-10-27 Gentili Ist Spa Associazione glibenclamide-metformina, composizioni farmaceutiche che la contengono e loro uso nel trattamento del diabete mellito di tipo
AP1224A (en) * 1998-03-19 2003-11-14 Bristol Myers Squibb Co Biphasic controlled release delivery system for high solubility pharmaceuticals and method.
ATE250418T1 (de) * 1998-07-15 2003-10-15 Merck Sante Sas Tabletten enthaltend eine kombination von glibenclamid und metformin
US6780432B1 (en) * 2000-05-01 2004-08-24 Aeropharm Technology, Inc. Core formulation
WO2002055009A1 (en) * 2001-01-12 2002-07-18 Sun Pharmaceutical Industries Limited Spaced drug delivery system

Also Published As

Publication number Publication date
MXPA04004974A (es) 2004-08-11
WO2003045355A1 (en) 2003-06-05
ITFI20010230A1 (it) 2003-05-29
HRP20040501A2 (en) 2004-12-31
HUP0402154A3 (en) 2008-04-28
MY141243A (en) 2010-03-31
ES2302862T3 (es) 2008-08-01
SI1458364T1 (sl) 2008-08-31
CO5590906A2 (es) 2005-12-30
AU2002358061A1 (en) 2003-06-10
TNSN04095A1 (en) 2006-06-01
JP2005518360A (ja) 2005-06-23
ZA200404880B (en) 2005-07-29
ATE387190T1 (de) 2008-03-15
PE20030580A1 (es) 2003-09-05
DE60225331T2 (de) 2009-02-26
EP1458364B1 (en) 2008-02-27
AU2002358061B2 (en) 2007-01-11
UY27549A1 (es) 2003-06-30
EP1458364A1 (en) 2004-09-22
PA8559801A1 (es) 2003-06-30
AR037407A1 (es) 2004-11-10
CN1596103A (zh) 2005-03-16
DE60225331D1 (de) 2008-04-10
HN2002000341A (es) 2009-12-07
CY1107966T1 (el) 2013-09-04
NZ533779A (en) 2007-02-23
KR20040079898A (ko) 2004-09-16
US20050053661A1 (en) 2005-03-10
IL162143A0 (en) 2005-11-20
EA006766B1 (ru) 2006-04-28
MA27087A1 (fr) 2004-12-20
BR0214403A (pt) 2004-10-19
CA2466677A1 (en) 2003-06-05
JP4474162B2 (ja) 2010-06-02
NO20042713L (no) 2004-07-16
HUP0402154A2 (hu) 2005-02-28
RS50937B (sr) 2010-08-31
PL369851A1 (pl) 2005-05-02
DK1458364T3 (da) 2008-06-23
PL206016B1 (pl) 2010-06-30
UA81615C2 (ru) 2008-01-25
RS47304A (sr) 2006-10-27
CN1596103B (zh) 2010-06-16
SV2004001415A (es) 2004-05-07
EA200400664A1 (ru) 2004-10-28
PT1458364E (pt) 2008-05-26
HK1069974A1 (en) 2005-06-10

Similar Documents

Publication Publication Date Title
EG24124A (en) Pharmaceutical compositions for the treatment of type-II diabetes mellitus
PL370818A1 (pl) Forma dawkowania przeznaczona do leczenia cukrzycy
IL158593A (en) Arylsulfonamide compounds, process for preparation thereof and pharmaceutical compositions for the treatment of obesity, type ii diabetes and cns-disorders
IL213806A0 (en) Use of derivatives of n-phenylpiperazin-1-yl-acetamide for the preparation of a pharmaceutical compositions for treatment of diabetes related conditions
EP1450824A4 (en) PHARMACEUTICAL COMPOSITION
AP2003002907A0 (en) Liquid pharmaceutical composition.
MXPA03006936A (es) Tratamiento de diabetes mellitus.
AU2000276362A1 (en) Composition for the treatment of diabetes
IL165012A0 (en) (S)-4-Amino-5-chloro-2-methoxy-N-Ä1-(-tetrahydrofurylcarbonyl)-4-piperidinylmethylÜ-4-piperidinylÜbenzamide, process for the preparation thereof, pharmaceutical composition containing the same, and intermediate therefor
HUP0303163A3 (en) Tramadol-based pharmaceutical composition
GB0117057D0 (en) Pharmaceutical composition
PL377164A1 (pl) Pochodne anilinopirazolu przydatne do leczenia cukrzycy
PL394600A1 (pl) Związek winyloazacykloalkanowy, sposób jego wytwarzania i jego zastosowanie oraz kompozycja farmaceutyczna
GB0129117D0 (en) Pharmaceutical composition
HUP0401612A3 (en) Pharmaceutical composition suitable for treating diabetes
GB0116107D0 (en) Pharmaceutical composition
PL370037A1 (pl) Kompozycja farmaceutyczna
GB2355189B (en) Herbal preparation for the treatment of diabetes mellitus
GB0212790D0 (en) Medicament for the treatment of diabetes
HUP0301137A3 (en) Thiazolidinedione salt for treatment of diabetes mellitus, process for its preparation and pharmaceutical composition containing the same
IL156861A0 (en) Pyrrole derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof
IL157411A0 (en) Pharmaceutical composition
GB9926061D0 (en) Compositions for the treatment of diabetes mellitus
HUP0201992A3 (en) Indenoindolone derivatives, process for their preparation and pharmaceutical compositions containing the compounds and their use
WO2004082591A8 (en) Pharmaceutical composition for treatment of diabetes mellitus